HBV - ALT / AST and ALT / AST Ratio (AAR)

HBV - ALT / AST and ALT / AST Ratio (AAR)

•	Elevated ALT and AST Predict Higher Mortality Risk in General Population 11/14/06

Hepatitis C
FDA-Approved
Treatments

Monotherapies
Intron A
Roferon
Infergen
Pegasys
PEG-Intron

Combination
Pegasys + Copegus
PEG-Intron + Rebetol
Intron A + Rebetol
Roferon A + Ribavirin

Hepatitis B
FDA-Approved
Treatments